• arclein
. Researchers at the Scripps Research Institute and Dutch biopharmaceutical company Crucell have now found a broadly acting antibody that could lead to a single, near-universal flu vaccine to replace annually changing vaccines.
Watch Streaming Broadcast Live:
LRN.fm
DLive
Live Chat Telegram
Share this page with your friends
on your favorite social network: